{"id":821574,"date":"2025-03-04T15:56:01","date_gmt":"2025-03-04T20:56:01","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-corporation-to-host-investor-conference-call-to-discuss-fiscal-year-2024-financial-results-and-provide-a-corporate-update-on-march-6-2025\/"},"modified":"2025-03-04T15:56:01","modified_gmt":"2025-03-04T20:56:01","slug":"daxor-corporation-to-host-investor-conference-call-to-discuss-fiscal-year-2024-financial-results-and-provide-a-corporate-update-on-march-6-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-corporation-to-host-investor-conference-call-to-discuss-fiscal-year-2024-financial-results-and-provide-a-corporate-update-on-march-6-2025\/","title":{"rendered":"Daxor Corporation to Host Investor Conference Call to Discuss Fiscal Year 2024 Financial Results and Provide a Corporate Update on March 6, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">\n        <strong>Oak Ridge, TN, March  04, 2025  (GLOBE NEWSWIRE) &#8212; <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hF1gnFnQsaHz_Yrkznn4Qme3tq-hCCrnGof56Rlb3XYGm62rPoW7BLHJSsl5CjhHFqpdAua11cNdsJ4j87Wxrg==\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong><br \/>\n            <u>Daxor Corporation<\/u><br \/>\n          <\/strong><br \/>\n        <\/a> (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces it will host an investor conference call on Thursday, March 6, 2025, at 4:30 p.m. ET.<\/p>\n<p align=\"justify\">President and CEO Michael Feldschuh and CFO Robert Michel will review financial results and provide an update on corporate developments. After Management\u2019s presentation, there will be an opportunity for Q&amp;A. Investors are encouraged to submit questions in advance via email to: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_RuvmKuuq80ICAQu3C8xyfvrRw_Nvs_twuUzOGlVnIG9fxkWOaWtehNORETvFlauJakvd1ZbAiMTeCDYQ7xuNw==\" rel=\"nofollow\" target=\"_blank\"><u>info@daxor.com<\/u><\/a>.<\/p>\n<p>To participate, register <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zYToZg2KutxNO-uoxYiKsFXjZUNoqjVaqru_vutETM3YGzcE6uczcgVmnOmq5zBTfRiWBEXwNpJiEPEcXNI6vzRR4DAccaIfKHnp6fB4v7glvhPh5sy4kos7zp0yfZ7i\" rel=\"nofollow\" target=\"_blank\"><u>HERE<\/u><\/a>.<\/p>\n<p>A webcast replay of the call will be available on the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hF1gnFnQsaHz_Yrkznn4QjpdT4G_c9jlMJZzy5QosvpTnyThSQsRQl-T-otPP3FVacdXOJbfyukQnt7l6M577w==\" rel=\"nofollow\" target=\"_blank\"><u>Daxor.com.<\/u><\/a><\/p>\n<p>\n        <strong>About Daxor Corporation<\/strong>\n      <\/p>\n<p align=\"justify\">Daxor Corporation (Nasdaq: DXR), is the global leader in blood volume measurement technology focused on blood volume testing innovation. We developed and market the BVA-100<sup>\u2122<\/sup> (Blood Volume Analyzer), the only diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms. Over 65,000+ tests have been performed at leading hospital centers across the U.S., enhancing hospital performance metrics in a broad range of surgical and medical conditions, including significantly reducing mortality and readmissions in heart failure and critical care. Daxor has several ongoing trials in the areas of heart failure treatment with support from the NIH and is under contract developing analyzers to improve combat casualty care with the U.S. Department of Defense. Daxor&#8217;s mission is to advance healthcare by enabling optimal fluid management with blood volume analysis. Daxor\u2019s vision is optimal blood volume for all. For more information, please visit our website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hF1gnFnQsaHz_Yrkznn4QhMkKBJcUbyzZtV4AHzKbgt5AUuGwgzU0M0hih-K7Qt2PV6XukD74k-wgm7mkfmgCA==\" rel=\"nofollow\" target=\"_blank\"><u>Daxor.com<\/u><\/a>. Sign up to receive news on Daxor\u2019s innovative technology <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zYToZg2KutxNO-uoxYiKsDsQK0GJwwN4qXFq8K8-RNTWe8k_avCqskG-eCjmjO-1Ho_ojRG9EfzQYrA8gHYszw==\" rel=\"nofollow\" target=\"_blank\"><u>HERE<\/u><\/a>.<\/p>\n<p>\n        <strong>Forward-Looking Statements<\/strong>\n      <\/p>\n<p align=\"justify\">Certain statements in this release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including without limitation, statements regarding the impact of hiring sales staff and expansion of our distribution channels. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this release, including, without limitation, those risk associated with our post-market clinical data collection activities, benefits of our products to patients, our expectations with respect to product development and commercialization efforts, our ability to increase market and physician acceptance of our products, potentially competitive product offerings, intellectual property protection, FDA regulatory actions, our ability to integrate acquired businesses, our expectations regarding anticipated synergies with and benefits from acquired businesses, and additional other risks and uncertainties described in our filings with the SEC. Forward-looking statements speak only as of the date when made. Daxor does not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.<\/p>\n<p>\n        <strong>Investor Relations Contact:<\/strong><br \/>\n        <br \/>Bret Shapiro<br \/>Sr. Managing Partner, CORE IR<br \/>1-516-222-2560<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5s0i1medbFLAgwdvySc4a_NPec3-D2q0t1Ik7uANeq-i0EIhHDPTNvEA4dHtRFhqWmSwBeqQ9t1a5ThjviCUaA==\" rel=\"nofollow\" target=\"_blank\"><u>brets@coreir.com<\/u><\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4ODk1NSM2NzkwNjc3IzIwODQzNDY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YWUzMGQyODUtOGIxMC00ZjljLTk4NWQtYWM4ZTM0YzljZjkzLTEwOTU5MTc=\/tiny\/Daxor-Corporation.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Oak Ridge, TN, March 04, 2025 (GLOBE NEWSWIRE) &#8212; Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces it will host an investor conference call on Thursday, March 6, 2025, at 4:30 p.m. ET. President and CEO Michael Feldschuh and CFO Robert Michel will review financial results and provide an update on corporate developments. After Management\u2019s presentation, there will be an opportunity for Q&amp;A. Investors are encouraged to submit questions in advance via email to: info@daxor.com. To participate, register HERE. A webcast replay of the call will be available on the Company\u2019s website at Daxor.com. About Daxor Corporation Daxor Corporation (Nasdaq: DXR), is the global leader in blood volume measurement technology focused on blood volume &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-corporation-to-host-investor-conference-call-to-discuss-fiscal-year-2024-financial-results-and-provide-a-corporate-update-on-march-6-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Daxor Corporation to Host Investor Conference Call to Discuss Fiscal Year 2024 Financial Results and Provide a Corporate Update on March 6, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-821574","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Daxor Corporation to Host Investor Conference Call to Discuss Fiscal Year 2024 Financial Results and Provide a Corporate Update on March 6, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-corporation-to-host-investor-conference-call-to-discuss-fiscal-year-2024-financial-results-and-provide-a-corporate-update-on-march-6-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Daxor Corporation to Host Investor Conference Call to Discuss Fiscal Year 2024 Financial Results and Provide a Corporate Update on March 6, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Oak Ridge, TN, March 04, 2025 (GLOBE NEWSWIRE) &#8212; Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces it will host an investor conference call on Thursday, March 6, 2025, at 4:30 p.m. ET. President and CEO Michael Feldschuh and CFO Robert Michel will review financial results and provide an update on corporate developments. After Management\u2019s presentation, there will be an opportunity for Q&amp;A. Investors are encouraged to submit questions in advance via email to: info@daxor.com. To participate, register HERE. A webcast replay of the call will be available on the Company\u2019s website at Daxor.com. About Daxor Corporation Daxor Corporation (Nasdaq: DXR), is the global leader in blood volume measurement technology focused on blood volume &hellip; Continue reading &quot;Daxor Corporation to Host Investor Conference Call to Discuss Fiscal Year 2024 Financial Results and Provide a Corporate Update on March 6, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-corporation-to-host-investor-conference-call-to-discuss-fiscal-year-2024-financial-results-and-provide-a-corporate-update-on-march-6-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-04T20:56:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4ODk1NSM2NzkwNjc3IzIwODQzNDY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/daxor-corporation-to-host-investor-conference-call-to-discuss-fiscal-year-2024-financial-results-and-provide-a-corporate-update-on-march-6-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/daxor-corporation-to-host-investor-conference-call-to-discuss-fiscal-year-2024-financial-results-and-provide-a-corporate-update-on-march-6-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Daxor Corporation to Host Investor Conference Call to Discuss Fiscal Year 2024 Financial Results and Provide a Corporate Update on March 6, 2025\",\"datePublished\":\"2025-03-04T20:56:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/daxor-corporation-to-host-investor-conference-call-to-discuss-fiscal-year-2024-financial-results-and-provide-a-corporate-update-on-march-6-2025\\\/\"},\"wordCount\":512,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/daxor-corporation-to-host-investor-conference-call-to-discuss-fiscal-year-2024-financial-results-and-provide-a-corporate-update-on-march-6-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4ODk1NSM2NzkwNjc3IzIwODQzNDY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/daxor-corporation-to-host-investor-conference-call-to-discuss-fiscal-year-2024-financial-results-and-provide-a-corporate-update-on-march-6-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/daxor-corporation-to-host-investor-conference-call-to-discuss-fiscal-year-2024-financial-results-and-provide-a-corporate-update-on-march-6-2025\\\/\",\"name\":\"Daxor Corporation to Host Investor Conference Call to Discuss Fiscal Year 2024 Financial Results and Provide a Corporate Update on March 6, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/daxor-corporation-to-host-investor-conference-call-to-discuss-fiscal-year-2024-financial-results-and-provide-a-corporate-update-on-march-6-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/daxor-corporation-to-host-investor-conference-call-to-discuss-fiscal-year-2024-financial-results-and-provide-a-corporate-update-on-march-6-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4ODk1NSM2NzkwNjc3IzIwODQzNDY=\",\"datePublished\":\"2025-03-04T20:56:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/daxor-corporation-to-host-investor-conference-call-to-discuss-fiscal-year-2024-financial-results-and-provide-a-corporate-update-on-march-6-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/daxor-corporation-to-host-investor-conference-call-to-discuss-fiscal-year-2024-financial-results-and-provide-a-corporate-update-on-march-6-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/daxor-corporation-to-host-investor-conference-call-to-discuss-fiscal-year-2024-financial-results-and-provide-a-corporate-update-on-march-6-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4ODk1NSM2NzkwNjc3IzIwODQzNDY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4ODk1NSM2NzkwNjc3IzIwODQzNDY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/daxor-corporation-to-host-investor-conference-call-to-discuss-fiscal-year-2024-financial-results-and-provide-a-corporate-update-on-march-6-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Daxor Corporation to Host Investor Conference Call to Discuss Fiscal Year 2024 Financial Results and Provide a Corporate Update on March 6, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Daxor Corporation to Host Investor Conference Call to Discuss Fiscal Year 2024 Financial Results and Provide a Corporate Update on March 6, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-corporation-to-host-investor-conference-call-to-discuss-fiscal-year-2024-financial-results-and-provide-a-corporate-update-on-march-6-2025\/","og_locale":"en_US","og_type":"article","og_title":"Daxor Corporation to Host Investor Conference Call to Discuss Fiscal Year 2024 Financial Results and Provide a Corporate Update on March 6, 2025 - Market Newsdesk","og_description":"Oak Ridge, TN, March 04, 2025 (GLOBE NEWSWIRE) &#8212; Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces it will host an investor conference call on Thursday, March 6, 2025, at 4:30 p.m. ET. President and CEO Michael Feldschuh and CFO Robert Michel will review financial results and provide an update on corporate developments. After Management\u2019s presentation, there will be an opportunity for Q&amp;A. Investors are encouraged to submit questions in advance via email to: info@daxor.com. To participate, register HERE. A webcast replay of the call will be available on the Company\u2019s website at Daxor.com. About Daxor Corporation Daxor Corporation (Nasdaq: DXR), is the global leader in blood volume measurement technology focused on blood volume &hellip; Continue reading \"Daxor Corporation to Host Investor Conference Call to Discuss Fiscal Year 2024 Financial Results and Provide a Corporate Update on March 6, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-corporation-to-host-investor-conference-call-to-discuss-fiscal-year-2024-financial-results-and-provide-a-corporate-update-on-march-6-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-04T20:56:01+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4ODk1NSM2NzkwNjc3IzIwODQzNDY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-corporation-to-host-investor-conference-call-to-discuss-fiscal-year-2024-financial-results-and-provide-a-corporate-update-on-march-6-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-corporation-to-host-investor-conference-call-to-discuss-fiscal-year-2024-financial-results-and-provide-a-corporate-update-on-march-6-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Daxor Corporation to Host Investor Conference Call to Discuss Fiscal Year 2024 Financial Results and Provide a Corporate Update on March 6, 2025","datePublished":"2025-03-04T20:56:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-corporation-to-host-investor-conference-call-to-discuss-fiscal-year-2024-financial-results-and-provide-a-corporate-update-on-march-6-2025\/"},"wordCount":512,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-corporation-to-host-investor-conference-call-to-discuss-fiscal-year-2024-financial-results-and-provide-a-corporate-update-on-march-6-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4ODk1NSM2NzkwNjc3IzIwODQzNDY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-corporation-to-host-investor-conference-call-to-discuss-fiscal-year-2024-financial-results-and-provide-a-corporate-update-on-march-6-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-corporation-to-host-investor-conference-call-to-discuss-fiscal-year-2024-financial-results-and-provide-a-corporate-update-on-march-6-2025\/","name":"Daxor Corporation to Host Investor Conference Call to Discuss Fiscal Year 2024 Financial Results and Provide a Corporate Update on March 6, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-corporation-to-host-investor-conference-call-to-discuss-fiscal-year-2024-financial-results-and-provide-a-corporate-update-on-march-6-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-corporation-to-host-investor-conference-call-to-discuss-fiscal-year-2024-financial-results-and-provide-a-corporate-update-on-march-6-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4ODk1NSM2NzkwNjc3IzIwODQzNDY=","datePublished":"2025-03-04T20:56:01+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-corporation-to-host-investor-conference-call-to-discuss-fiscal-year-2024-financial-results-and-provide-a-corporate-update-on-march-6-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/daxor-corporation-to-host-investor-conference-call-to-discuss-fiscal-year-2024-financial-results-and-provide-a-corporate-update-on-march-6-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-corporation-to-host-investor-conference-call-to-discuss-fiscal-year-2024-financial-results-and-provide-a-corporate-update-on-march-6-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4ODk1NSM2NzkwNjc3IzIwODQzNDY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4ODk1NSM2NzkwNjc3IzIwODQzNDY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/daxor-corporation-to-host-investor-conference-call-to-discuss-fiscal-year-2024-financial-results-and-provide-a-corporate-update-on-march-6-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Daxor Corporation to Host Investor Conference Call to Discuss Fiscal Year 2024 Financial Results and Provide a Corporate Update on March 6, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/821574","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=821574"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/821574\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=821574"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=821574"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=821574"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}